Buy Picamilon Sodium
Picamilon is a linked derivative of the vitamin Niacin (vitamin B3, nicotinic acid) with the inhibitory neurotransmitter GABA
CAS Number | 62936-56-5 |
---|---|
Appearance | Powder |
Chemical Names | Picamilon, Pikamilone sodium salt, Pikamilone, Pikamilon sodium salt, Nicotinoyl-GABA sodium salt, 4-(Pyridine-3-carbonylamino)butanoic acid sodium salt, Monosodium 4-(pyridine-3-carbonylamino)butanoate, Monosodium 4-Nicotinoylaminobutyrate, N-(3-Pyridinylcarbonyl)-4-aminobutyric acid sodium |
Molecular Formula | C10H11N2O3 •Na |
Molecular Weight | 230.20 g/mol |
Picamilon Sodium stands out as an effective stress relief supplement renowned for its calming and stress-reducing effects. Its primary advantage lies in its ability to promote relaxation, reduce stress levels, and support overall well-being. it offers comprehensive stress relief, making it an ideal choice for individuals seeking to manage stress and enhance their mental state.
it is a potent stress relief supplement formulated to promote relaxation, reduce stress, and enhance overall well-being. This supplement provides stress-relieving benefits without the typical side effects associated with traditional stress management solutions, making it a preferred option for individuals looking to improve their mental state and manage stress.
How to use Picamilon Sodium Powder:
- Stress relief and relaxation support
- Calming effects and stress reduction
- Overall well-being promotion
How to Use Picamilon Sodium:
- Dosage: Begin with a moderate dose, such as 50 mg to 100 mg per day, and adjust based on individual response.
- Timing: Take as needed for stress relief and relaxation support.
- Administration: Mix the powder with water or a beverage and consume orally.
- Stacking: Combine with other stress relief supplements for enhanced benefits. Consult a healthcare provider before adding it to your supplement routine.
Order Picamilon Sodium now from Nootropic Sources to experience stress relief and promote relaxation!
Reviews
There are no reviews yet.